{"disease":{"id":"infections-staphylococcal","name":"infections staphylococcal"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04141787","title":"Ceftriaxone as Home IV for Staph Infections","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":310,"lead_sponsor_name":"Vancouver Island Health Authority","has_results":false},{"nct_id":"NCT02814916","title":"Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT01160172","title":"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}